Global Exocrine Pancreatic Insufficiency Market Report By Disease Management (Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Life Style Modifications Approach); By Therapeutics Drugs (Creon, Zenpep, Pancreaze, Ultresa, Viokace And Pertzye), By Diagnosis (Magnetic resonance imaging (MRI), CT scanning, Endoscopic ultra-sonography (EUS), Blood tests And Other tests) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11211615
February 2020
Report Formats:

The global demand for Exocrine Pancreatic Insufficiency Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
 
Exocrine pancreatic insufficiency directs to a medical situation that is characterized by the shortage of the exocrine pancreatic enzymes in the body. This shortage impacts in mal-digestion or the difficulty in the complete digestion of food. The diagnosis of such a disorder is frequently solely clinical because the indications and symptoms of the disease often remain hidden. This disease, therefore, can only be observed by different diagnostic experiments such as blood, stool, and pancreatic process tests.
 
In the recent era, there are a vast number of favorable components giving major momentum to the exocrine pancreatic insufficiency therapeutics market movements. There is enhanced awareness in terms of this disorder and the probable negative or unfavorable impact if it is ignored. A number of persistent and severe disorders such as celiac disease and tumors are correlated with exocrine pancreatic insufficiency which contributes to the growth.
 
Market Dynamics
 
The prominent factor participating in the growth of the global market is a plurality of several chronic pancreatic disorders that often lead to exocrine pancreatic insufficiency. Even if the majority of exocrine pancreatic insufficiency in the population is hard to measure, an abundance of main gastrointestinal disorders is related to this disease. This is anticipated to abruptly increase its prevalence, enhancing the exocrine pancreatic insufficiency therapeutics market growth in the forecast period.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of exocrine pancreatic insufficiency.
 
Market Segmentation
 
The entire exocrine pancreatic insufficiency market has been sub-categorized into disease management, therapeutics drugs and diagnosis. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Disease Management

  • Nutritional Management
  • Pancreatic Enzyme Replacement Therapy (PERT)
  • Life Style Modifications Approach
 
By Therapeutics Drugs
  • Creon
  • Zenpep
  • Pancreaze
  • Ultresa
  • Viokace
  • Pertzye
 
By Diagnosis
  • Magnetic resonance imaging (MRI)
  • CT scanning
  • Endoscopic ultra-sonography (EUS)
  • Blood tests
  • Other tests
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for exocrine pancreatic insufficiency market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Exocrine Pancreatic Insufficiency Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the exocrine pancreatic insufficiency market include Abbvie Inc., Allergan plc., Nordmark Arzneimittel GmbH & Co. KG, Digestive Care, Inc., Cilian AG, Anthera Pharmaceuticals Inc., Janssen Pharmaceuticals Inc. and AzurRx BioPharma Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                          
 
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Exocrine Pancreatic Insufficiency Market
       2.2. Global Exocrine Pancreatic Insufficiency Market Snapshot
 
3 . EXOCRINE PANCREATIC INSUFFICIENCY – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Exocrine Pancreatic Insufficiency Market
       3.3. Market Restraints of Exocrine Pancreatic Insufficiency Market
       3.4. Opportunities of Exocrine Pancreatic Insufficiency Market
       3.5. Trends of Exocrine Pancreatic Insufficiency Market
       3.6. Porter’s Five Force Analysis of Exocrine Pancreatic Insufficiency Market
       3.7. Exocrine Pancreatic Insufficiency Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Disease Management
           3.7.2 Market Attractive Analysis by Therapeutics Drugs
           3.7.3 Market Attractive Analysis by Diagnosis
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Exocrine Pancreatic Insufficiency Value Chain Analysis
       4.2. Exocrine Pancreatic Insufficiency Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Exocrine Pancreatic Insufficiency Raw Material Manufactures List
           4.2.3. Price Trend of Exocrine Pancreatic Insufficiency Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL EXOCRINE PANCREATIC INSUFFICIENCY MARKET ANALYSIS BY DISEASE MANAGEMENT
       5.1 Overview by Disease Management
       5.2 Global Exocrine Pancreatic Insufficiency Market Analysis by Disease Management
       5.3 Market Analysis of Nutritional Management by Regions
       5.4 Market Analysis of Pancreatic Enzyme Replacement Therapy (PERT) by Regions
       5.5 Market Analysis of Life Style Modifications Approach by Regions
 
6 . GLOBAL EXOCRINE PANCREATIC INSUFFICIENCY MARKET ANALYSIS BY THERAPEUTICS DRUGS
       6.1 Overview by Therapeutics Drugs
       6.2 Global Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics Drugs
       6.3 Market Analysis of Creon by Regions
       6.4 Market Analysis of Zenpep by Regions
       6.5 Market Analysis of Pancreaze by Regions
       6.6 Market Analysis of Ultresa by Regions
       6.7 Market Analysis of Viokace by Regions
       6.8 Market Analysis of Pertzye by Regions
 
7 . GLOBAL EXOCRINE PANCREATIC INSUFFICIENCY MARKET ANALYSIS BY DIAGNOSIS
       7.1 Overview by Diagnosis
       7.2 Global Exocrine Pancreatic Insufficiency Market Analysis by Diagnosis
       7.3 Market Analysis of Magnetic resonance imaging (MRI) by Regions
       7.4 Market Analysis of CT scanning by Regions
       7.5 Market Analysis of Endoscopic ultra-sonography (EUS) by Regions
       7.6 Market Analysis of Blood tests by Regions
       7.7 Market Analysis of Other tests by Regions
 
8 . GLOBAL EXOCRINE PANCREATIC INSUFFICIENCY MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Exocrine Pancreatic Insufficiency Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
           8.4.3. Europe Exocrine Pancreatic Insufficiency Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
           8.5.3. Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
           8.6.3. Latin America Exocrine Pancreatic Insufficiency Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
           8.7.3. Middle East & Africa Exocrine Pancreatic Insufficiency Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE EXOCRINE PANCREATIC INSUFFICIENCY COMPANIES
       9.1. Exocrine Pancreatic Insufficiency Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF EXOCRINE PANCREATIC INSUFFICIENCY INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Abbvie Inc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Allergan plc.
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Nordmark Arzneimittel GmbH & Co. KG
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Digestive Care, Inc.
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Cilian AG
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Anthera Pharmaceuticals Inc.
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Janssen Pharmaceuticals Inc.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. AzurRx BioPharma Inc.
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Exocrine Pancreatic Insufficiency Market Snapshot
  • Drivers of The Global Exocrine Pancreatic Insufficiency Market Impact Analysis
  • Restraints of The Global Exocrine Pancreatic Insufficiency Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Nutritional Management by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Pancreatic Enzyme Replacement Therapy (PERT) by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Life Style Modifications Approach by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics Drugs (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Creon by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Zenpep by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Pancreaze by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Ultresa by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Viokace by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Pertzye by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis by Diagnosis (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Magnetic resonance imaging (MRI) by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in CT scanning by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Endoscopic ultra-sonography (EUS) by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Blood tests by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Other tests by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market by Geography (USD MN)
  • North America Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • North America Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • North America Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • North America Exocrine Pancreatic Insufficiency Market Estimate by Country (USD MN)
  • United State Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • United State Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • United State Exocrine Pancreatic Insufficiency Market Analysis by Diagnosis (USD MN)
  • Rest of North America Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Rest of North America Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • Rest of North America Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis(USD MN)
  • Europe Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Europe Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • Europe Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • United Kingdom Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • United Kingdom Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • United Kingdom Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • France Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • France Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • France Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • Germany Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Germany Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • Germany Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • Rest of Europe Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Rest of Europe Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • Rest of Europe Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • Asia Pacific Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Country (USD MN)
  • China Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • China Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • China Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • Japan Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Japan Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • Japan Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • India Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • India Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • India Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • Rest of Asia Pacific Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Rest of Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • Rest of Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • Latin America Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Latin America Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • Latin America Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • Latin America Exocrine Pancreatic Insufficiency Market Estimate by Country (USD MN)
  • Brazil Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Brazil Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • Brazil Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • Rest of Latin America Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Rest of Latin America Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • Rest of Latin America Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • Middle East & Africa Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Middle East & Africa Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • Middle East & Africa Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • Middle East & Africa Exocrine Pancreatic Insufficiency Market Estimate by Country (USD MN)
  • Middle East Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Middle East Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • Middle East Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • Africa Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Africa Exocrine Pancreatic Insufficiency Market Estimate by Therapeutics Drugs (USD MN)
  • Africa Exocrine Pancreatic Insufficiency Market Estimate by Diagnosis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Exocrine Pancreatic Insufficiency Report
  • Market Research Process
  • Market Research Methodology
  • Global Exocrine Pancreatic Insufficiency Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Disease Management
  • Market Attractiveness Analysis by Therapeutics Drugs
  • Market Attractiveness Analysis by Diagnosis
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Exocrine Pancreatic Insufficiency Market Analysis by Disease Management (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Nutritional Management by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Pancreatic Enzyme Replacement Therapy (PERT) by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Life Style Modifications Approach by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics Drugs (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Creon by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Zenpep by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Pancreaze by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Ultresa by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Viokace by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Pertzye by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis by Diagnosis (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Magnetic resonance imaging (MRI) by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in CT scanning by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Endoscopic ultra-sonography (EUS) by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Blood tests by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Other tests by Geography (USD MN)
  • Latin America Exocrine Pancreatic Insufficiency Market by Revenue
  • Middle East & Africa Exocrine Pancreatic Insufficiency Market by Revenue
  • Recent Development in Exocrine Pancreatic Insufficiency Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials